Skip to main content

Advertisement

Log in

Can oral isotretinoin be safely initiated and monitored in primary care? A case series

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

Oral isotretinoin has traditionally been prescribed only in secondary care for severe or resistant acne.

Aims

To explore whether this drug can be safely initiated and monitored in primary care by a GP with extra training in dermatology.

Method

One hundred consecutive patients who were started on oral isotretinoin therapy in a primary care centre were retrospectively reviewed.

Results

One hundred percent of the patients with acne who completed their course of isotretinoin were cleared at the end of treatment. Twenty-three of the eighty-one patients (28%) who were followed-up after a mean of 5 years relapsed and eighteen (22%) had to have at least one more course of isotretinoin. Seventy-four of seventy-seven (96%) patients who had long-term follow-up were satisfied with the level of care they received in primary care.

Conclusion

This study suggests that oral isotretinoin can be safely initiated and monitored by a GP with a special interest in dermatology and experience in prescribing systemic retinoids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Dawson AL, Dellavalle RP (2013) Acne vulgaris. BMJ 346:f2634

    Article  PubMed  Google Scholar 

  2. Bhate K, Williams HC (2013) Epidemiology of acne vulgaris. Br J Dermatol 168(3):474–485

    Article  CAS  PubMed  Google Scholar 

  3. Marqueling AL, Zane LT (2007) Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg 26(4):210–220

    Article  CAS  PubMed  Google Scholar 

  4. Ayer J, Burrows N (2006) Acne: more than skin deep. Postgrad Med J 82(970):500–506

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Mallon E, Newton JN, Klassen A et al (1999) The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 140(4):672–676

    Article  CAS  PubMed  Google Scholar 

  6. Zomerdijk IM, Ruiter R, Houweling LMA et al (2014) Isotretinoin exposure during pregnancy: a population-based study in The Netherlands. BMJ Open 4(11):e005602. doi:10.1136/bmjopen-2014-005602

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kontaxakis VP, Skourides D, Ferentinos P et al (2009) Isotretinoin and psychopathology: a review. Ann Gen Psychiatry 8:2. doi:10.1186/1744-859X-8-2

    Article  PubMed  PubMed Central  Google Scholar 

  8. Magin P, Pond D, Smith W (2005) Isotretinoin, depression and suicide: a review of the evidence. Br J Gen Pract 55(511):134–138

    PubMed  PubMed Central  Google Scholar 

  9. Goodfield MJD, Cox NH, Bowser A et al (2010) Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010. Br J Dermatol 162(6):1172–1179. doi:10.1111/j.1365-2133.2010.09836.x

    Article  CAS  PubMed  Google Scholar 

  10. https://www.hpra.ie/img/uploaded/swedocuments/LicenseSPC_PA0050-053-004_24072015121051.pdf. Accessed 7 Jan 2017

  11. Layton AM, Knaggs H, Taylor J, Cunliffe WJ (1993) Isotretinoin for acne vulgaris-10 years later; a safe and successful treatment. Br J Dermatol 129:292–296

    Article  CAS  PubMed  Google Scholar 

  12. Azoulay L, Oraichi D, Bérard A (2007) Isotretinoin therapy and the incidence of acne relapse: a nested case–control study. Br J Dermatol 157(6):1240–1248 Epub 2007 Oct 26

    Article  CAS  PubMed  Google Scholar 

  13. Buckley D, Rogers S, Daly P (1990) Isotretinoin therapy for acne vulgaris: results in an Irish population. Ir J Med Sci 159(1):2–5

    Article  CAS  PubMed  Google Scholar 

  14. Newcombe RG (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17:857–872

    Article  CAS  PubMed  Google Scholar 

  15. Tenner S (2014) Isotretinoin and inflammatory bowel disease: trial lawyer misuse of science and FDA warnings. Am J Gastroenterol 109(4):570–571. doi:10.1038/ajg.2014.34

    Article  PubMed  Google Scholar 

  16. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Isotretinoin_29/WC500010881.pdf. Accessed 7 Jan 2017

Download references

Acknowledgements

We would like to thank all our patients who co-operated with us in completing this important work. We would also like to Tadhg O’ Shea (Institute of Technology, Tralee) who assisted with statistical analysis. Finally, we would like to thank our local GP colleagues who entrusted their patients to our care for the management of their troublesome acne.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Buckley.

Ethics declarations

Conflict of interest

None.

Ethical approval

This was obtained from the Clinical Research and Ethics Committee, University College Cork, Ireland.

Informed consent

Informed consent was obtained from all individual participants in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buckley, D., Yoganathan, S. Can oral isotretinoin be safely initiated and monitored in primary care? A case series. Ir J Med Sci 186, 315–319 (2017). https://doi.org/10.1007/s11845-016-1540-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-016-1540-5

Keywords

Navigation